Levena Pharma

Levena Pharma is a specialized biotechnology company focused on the design, development, and manufacturing of Antibody-Drug Conjugates (ADCs). Operating as a subsidiary of Sorrento Therapeutics, Levena offers a full range of ADC-related services, including the synthesis of complex linker-payloads and site-specific conjugation using its proprietary K-Lock and C-Lock platforms. These technologies are designed to create highly stable and homogeneous ADCs, addressing the limitations of traditional random conjugation methods. With dual operations in San Diego, California, and Suzhou, China, the company provides both contract research (CRO) and contract development and manufacturing (CDMO) services to global pharmaceutical partners. Levena plays a critical role in advancing next-generation cancer therapies by optimizing the delivery of cytotoxic agents to specific tumor cells.